Human papillomavirus infection and tumor microenvironment are associated with the microbiota in patients with oropharyngeal cancers—pilot study

Head & Neck ◽  
2021 ◽  
Author(s):  
Martha Zakrzewski ◽  
Orla Margaret Gannon ◽  
Benedict James Panizza ◽  
Nicholas Andrew Saunders ◽  
Annika Antonsson
Keyword(s):  
Human Papillomavirus ◽  
Pilot Study ◽  
Tumor Microenvironment ◽  
Human Papillomavirus Infection ◽  
Papillomavirus Infection

A pilot study to investigate the treatment of cervical human papillomavirus infection with zinc-citrate compound (CIZAR®)

2011 ◽  
Vol 122 (2) ◽  
pp. 303-306 ◽  
Author(s):  
Jin Hwi Kim ◽  
Seog Nyeon Bae ◽  
Chung Won Lee ◽  
Min Jong Song ◽  
Sung Jong Lee ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Pilot Study ◽  
Human Papillomavirus Infection ◽  
Papillomavirus Infection ◽  
Cervical Human Papillomavirus

Epidemiology of Human Papillomavirus Infection

2000 ◽  
Vol 34 (6) ◽  
pp. 194-200 ◽  
Author(s):  
Joakim Dillner ◽  
Chris J. L. M. Meijer ◽  
Geo von Krogh ◽  
Simon Horenblas
Keyword(s):  
Human Papillomavirus ◽  
Human Papillomavirus Infection ◽  
Papillomavirus Infection

Management of patients in conditions of female consultation at persistent course of papillomavirus infection of the cervix

2017 ◽  
pp. 34-36
Author(s):  
N.A. Shcherbina ◽  
◽  
D.I. Demidenko ◽  
A.D. Demidenko ◽  
N.V. Kapustnik ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Key Words ◽  
Maximum Effect ◽  
Cervical Epithelium ◽  
Results Of Treatment ◽  
Human Papillomavirus Infection ◽  
Papillomavirus Infection ◽  
Complex Therapy ◽  
Effect Of Treatment

Under our supervision there were 66 women with a diagnosis of "dysplasia of cervical epithelium mild" on the background of persistent human papillomavirus infection (PVI). With the aim of improving the treatment of dysplasia of the 1st degree in rehabilitation activities after cryoablation there were applied drugs Distreptaza and inducer of interferon. The results of treatment were evaluated after 3 months. For patients of the 1st group (18 women) who underwent only cryoablation, the efficacy of therapy was 77.8%. In the 2nd group (22 women) after cryoablation was used inducer of interferon, the effectiveness made up of 90.9%. The maximum effect of treatment - 100% recorded in 3rd group (26 patients), where after cryoablation was carried out treatment with Distreptaza and inducer of interferon. The results of treatment obtained in this group allow to recommend the complex therapy of PVI in conditions of female consultation. Key words: dysplasia, HPV, cryosurgery, Distreptaza, inducer of interferon.

Sign in / Sign up

Export Citation Format

Share Document